Glaxosmithkline | GSK - Current Liabilities

Stock Price
54.43
Daily Change
-4.69 -7.93%
Monthly
-8.15%
Yearly
45.42%
Q2 Forecast
57.29

Glaxosmithkline reported GBP28.82B in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
Amgen USD 25.49B 3.7B Dec/2025
AstraZeneca USD 30.62B 3.44B Dec/2025
Aurora Cannabis CAD 145.94M 21.82M Dec/2025
Bausch Health Companies USD 4.18B 613M Dec/2025
Bristol-Myers Squibb USD 28.14B 608M Sep/2025
Canopy Growth CAD 98.29M 17.19M Dec/2025
Corcept Therapeutics USD 166.08M 6.18M Dec/2025
Drreddys Laboratories INR 1.76B 62.5M Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
GlaxoSmithKline GBP 21.39B 57M Dec/2025
Glaxosmithkline GBP 28.82B 144.79M Dec/2025
J&J USD 57.72B 3.59B Mar/2026
Merck USD 28.63B 2.59B Sep/2025
Novartis USD 27.28B 4.72B Dec/2025
Pacira USD 120.59M 13.51M Dec/2025
Perrigo USD 1.01B 132.4M Dec/2025
Pfizer USD 36.6B 1.13B Sep/2025
Phibro Animal Health USD 282.37M 12.23M Dec/2025
Prestige Brands USD 139.56M 4.95M Dec/2025
Roche Holding CHF 28B 421M Dec/2025
Sanofi EUR 30.01B 1.66B Mar/2026
Supernus Pharmaceuticals USD 338.17M 7.54M Dec/2025
Takeda JPY 2.61T 470.53B Dec/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025
Zoetis USD 2.24B 428M Dec/2025